Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar
- 1 July 1997
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 91 (4) , 468-472
- https://doi.org/10.1016/s0035-9203(97)90288-1
Abstract
In Rakhine State, on the western border of Myanmar, the efficacy of chloroquine (CQ) and pyrimethamine/sulfadoxine (PS), the current treatments for uKeywords
This publication has 11 references indexed in Scilit:
- Systematic review of amodiaquine treatment in uncomplicated malariaThe Lancet, 1996
- Effects of artemisinin derivatives on malaria transmissibilityThe Lancet, 1996
- Changes in weight gain and anaemia attributable to malaria in Tanzanian children living under holoendemic conditionsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- Inhibition of tumour necrosis factor (TNF) production by antimalarial drugs used in cerebral malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Treatment Of Multidrug-Resistant Plasmodium Falciparum Malaria With 3-Day Artesunate-Mefloquine CombinationThe Journal of Infectious Diseases, 1994
- Antimalarial drug resistance: the pace quickensJournal of Antimicrobial Chemotherapy, 1992
- Amodiaquine Less Effective than Chloroquine in the Treatment of Falciparum Malaria in the PhilippinesThe American Journal of Tropical Medicine and Hygiene, 1987
- INTRAVENOUS AMODIAQUINE AND ORAL AMODIAQUINE/ERYTHROMYCIN IN THE TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIAThe Lancet, 1985